HLA class II alleles in Chinese patients with hepatocellular carcinoma

被引:18
作者
Donaldson, PT [1 ]
Ho, S
Williams, R
Johnson, PJ
机构
[1] Univ Newcastle, Liver Res Ctr, Sch Clin Med Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
[2] Chinese Univ Hong Kong, Prince Wales Hosp, Sir YK Pao Canc Ctr, Dept Clin Oncol, Shatin, Hong Kong, Peoples R China
[3] UCL Royal Free & Univ Coll Med Sch, Inst Hepatol, London, England
来源
LIVER | 2001年 / 21卷 / 02期
关键词
hepatocellular carcinoma (HCC); human leucocyte antigens (HLA); hepatitis B virus (HBV); Hong Kong Chinese; susceptibility; genetic associations;
D O I
10.1034/j.1600-0676.2001.021002143.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: Recent reports of an association between human leucocyte antigens (HLA) and persistence of hepatitis B virus infection, and the familial clustering of hepatocellular carcinoma raise the question of genetic susceptibility Previous studies have been limited to serological phenotyping of HLA B and DR antigens. The aim of this study was to use molecular genotyping to investigate HLA class II as a risk factor for the development of hepatocellular wt-cinema in Hong Kong Chinese. Methods. We determined HLA DRB1, DQA1, DQB1 and DPB1 alleles in 123 hepatitis B surface antigen positive patients (84 with hepatocellular carcinoma and 39 without) and 124 matched controls. Results: The alleles DRB1*1501 (36% of HCC patients ver sus 19% of controls, odds ratio = 2.44), DQA1*0.102 (42% versus 76%, odds ratio=2.07), and DPB1*0501 (80% versus 63%, odds rsttio-2.35) were significantly more common in patients with hepatocellular carcinoma, and DQA1*03 (36% versus 56%, odds ratio=0.53), DQB1*0302 (4.% versus 13%, odds ratio=0.25) and DPB1*0201 (14% versus 29%, odds ratio=0.4) were found at significantly lower frequencies. Conclusions: Although none of these associations was significant after correction for multiple testing, this report suggests that further investigations are warranted.
引用
收藏
页码:143 / 148
页数:6
相关论文
共 65 条
[1]   HLA AND HEPATITIS-B INFECTION [J].
ALMARRI, A ;
BATCHELOR, JR .
LANCET, 1994, 344 (8931) :1194-1195
[2]   Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection [J].
Alric, L ;
Fort, M ;
Izopet, J ;
Vinel, JP ;
Charlet, JP ;
Selves, J ;
Puel, J ;
Pascal, JP ;
Duffaut, M ;
Abbal, M .
GASTROENTEROLOGY, 1997, 113 (05) :1675-1681
[3]   COMPARISON OF HUMAN-LEUKOCYTE ANTIGEN DR-DQ DISEASE ASSOCIATIONS FOUND WITH CERVICAL DYSPLASIA AND INVASIVE CERVICAL-CARCINOMA [J].
APPLE, RJ ;
BECKER, TM ;
WHEELER, CM ;
ERLICH, HA .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (06) :427-436
[4]  
BEASLEY RP, 1988, CANCER, V61, P1942, DOI 10.1002/1097-0142(19880515)61:10<1942::AID-CNCR2820611003>3.0.CO
[5]  
2-J
[6]  
BEASLEY RP, 1982, HEPATOLOGY, V2, pS21
[7]  
BEASLEY RP, 1981, LANCET, V2, P1129
[8]   ABNORMAL STRUCTURE AND EXPRESSION OF P53 GENE IN HUMAN HEPATOCELLULAR-CARCINOMA [J].
BRESSAC, B ;
GALVIN, KM ;
LIANG, TJ ;
ISSELBACHER, KJ ;
WANDS, JR ;
OZTURK, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (05) :1973-1977
[9]   SELECTIVE G-MUTATION TO T-MUTATION OF P53 GENE IN HEPATOCELLULAR-CARCINOMA FROM SOUTHERN AFRICA [J].
BRESSAC, B ;
KEW, M ;
WANDS, J ;
OZTURK, M .
NATURE, 1991, 350 (6317) :429-431
[10]  
CHAN SH, 1980, J NATL CANCER I, V65, P21